Skip to main content

Quanterix Corp

corporate_fare Company Profile

Quanterix Corp

QTRX·NASDAQ·Industrial Applications And Services·CIK 0001503274

Quanterix Corp is a life sciences company that transforms healthcare innovation by accelerating biomarker breakthroughs from discovery to diagnostics. The company uses ultra-sensitive translational research and spatial biology instruments, consumables, and services. Quanterix focuses on shifting healthcare towards earlier detection, monitoring, prognosis, and prevention. Its combined platforms have an installed base of over 2,500 instruments and have been cited in more than 6,200 scientific publications, covering areas such as neurology, oncology, immunology, and inflammation. The company's proprietary digital "Simoa" detection technology allows customers to reliably detect protein biomarkers at ultra-low concentrations in blood, serum, and other fluids, often undetectable by conventional analog immunoassay technologies. Its "Spatial Biology" platforms enable multi-plexing biomarker analysis in tissue samples, helping scientists understand localized cellular interactions. The Simoa platforms can detect proteins in the femtomolar range, aiding in the development of novel therapies and diagnostics and potentially identifying early-stage disease markers. Quanterix sells its proprietary instruments and related consumables worldwide to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies. Additionally, the company provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. This laboratory, located in Bedford, Massachusetts, is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA).

Quanterix Corp (NASDAQ:QTRX) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 20 items for QTRX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-18, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for QTRX spans 10-Q, 8-K, DEF 14A, 10-K.

Recent high-impact activity:

  • CEO Exits Immediately; Commercial Chief Takes Over as Interim
  • Quanterix Posts $35M in Third-Quarter Revenue
  • Quanterix Wins China NMPA Approval for SIMOA Instruments and Four Alzheimer's Biomarker Tests
  • Quanterix Falls Short in Q2, Cuts 2026 Revenue Outlook by 15%, and Delays Breakeven to 2027
  • Quanterix Slashes 2026 Revenue Outlook by 15%, Delays Breakeven

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$138.9M
Net Income
-$107.15M
Diluted EPS
-$2.51
Op. Cash Flow
-$77.24M
Free Cash Flow
-$79.85M
Gross Profit
$64.96M
Operating Income
-$125.54M
Cash & Equivalents
$29.84M
Debt / Equity
0.00×
Net Margin
-77.1%
Shares Outstanding
46.74M sh
Source: 10-K · filed 2026-03-02 · accession 0001503274-26-000013

Short Interest & Short Volume

10.74 days to cover

FINRA reported short interest of 4,563,132 shares in QTRX as of the October 30, 2026 settlement, a 2.5% decrease from the prior period — about 10.7 days to cover at its recent average daily volume. On November 20, 2026, 53.6% of QTRX volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)4,563,132 shares as of October 30, 2026
Change vs prior period▼ 2.5%
Days to cover10.74 at avg daily volume of 424,974
Daily short volume (FINRA facilities)53.6% of 523,657 shares on November 20, 2026
5-day average short volume51.6%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with Q →
$1.99 +1.53% today
52-week range · as of 2026-08-10 $1.99 – $8.77
Market cap
$93.06M
Volume
1.1M (1.6× avg)
3-mo avg 666.1K
Live data · 2026-11-21 14:40 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed QTRX - Latest Insights

QTRX
Nov 18, 2026, 8:03 AM EST
Source: BusinessWire
Importance Score:
8
Updated Nov 18, 8:54 AM ET — Interim CEO Jim Gute will be paid a $750,000 annualized salary while serving in the role.
Price at Filing: $2.86
Real-time Price: $1.99 info
Change: -$0.870 (-30%) info
Market Cap: $93.058M info
QTRX
Nov 09, 2026, 8:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $2.90
Real-time Price: $1.99 info
Change: -$0.905 (-31%) info
Market Cap: $93.058M info
QTRX
Oct 07, 2026, 8:00 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $3.44
Real-time Price: $1.99 info
Change: -$1.45 (-42%) info
Market Cap: $93.058M info
QTRX
Aug 10, 2026, 8:34 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.58
Real-time Price: $1.99 info
Change: -$0.590 (-23%) info
Market Cap: $93.058M info
QTRX
Aug 10, 2026, 8:12 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $2.71
Real-time Price: $1.99 info
Change: -$0.720 (-27%) info
Market Cap: $93.058M info
QTRX
Aug 10, 2026, 8:07 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.68
Real-time Price: $1.99 info
Change: -$0.690 (-26%) info
Market Cap: $93.058M info
QTRX
Jun 10, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.07
Real-time Price: $1.99 info
Change: -$1.08 (-35%) info
Market Cap: $93.058M info
QTRX
Jun 10, 2026, 3:13 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $3.20
Real-time Price: $1.99 info
Change: -$1.21 (-38%) info
Market Cap: $93.058M info
QTRX
Jun 09, 2026, 8:06 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.67
Real-time Price: $1.99 info
Change: -$1.68 (-46%) info
Market Cap: $93.058M info
QTRX
May 26, 2026, 5:25 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.68
Real-time Price: $1.99 info
Change: -$0.690 (-26%) info
Market Cap: $93.058M info
QTRX
May 12, 2026, 4:17 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.91
Real-time Price: $1.99 info
Change: -$0.920 (-32%) info
Market Cap: $93.058M info
QTRX
May 06, 2026, 4:38 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $3.22
Real-time Price: $1.99 info
Change: -$1.23 (-38%) info
Market Cap: $93.058M info
QTRX
May 06, 2026, 4:13 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $3.35
Real-time Price: $1.99 info
Change: -$1.36 (-41%) info
Market Cap: $93.058M info
QTRX
May 06, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.35
Real-time Price: $1.99 info
Change: -$1.36 (-41%) info
Market Cap: $93.058M info
QTRX
Apr 24, 2026, 8:10 AM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $3.17
Real-time Price: $1.99 info
Change: -$1.18 (-37%) info
Market Cap: $93.058M info
QTRX
Mar 02, 2026, 4:35 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $6.33
Real-time Price: $1.99 info
Change: -$4.34 (-69%) info
Market Cap: $93.058M info
QTRX
Mar 02, 2026, 4:28 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.23
Real-time Price: $1.99 info
Change: -$4.24 (-68%) info
Market Cap: $93.058M info
QTRX
Mar 02, 2026, 4:04 PM EST
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $6.33
Real-time Price: $1.99 info
Change: -$4.34 (-69%) info
Market Cap: $93.058M info
QTRX
Mar 02, 2026, 4:01 PM EST
Source: Reuters
Importance Score:
8
Price at Filing: $6.33
Real-time Price: $1.99 info
Change: -$4.34 (-69%) info
Market Cap: $93.058M info
QTRX
Jan 08, 2026, 4:46 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $6.64
Real-time Price: $1.99 info
Change: -$4.65 (-70%) info
Market Cap: $93.058M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets